Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of the combination of
bendamustine and rituximab in patients with relapsed/refractory mantle cell lymphoma.